Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.
The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s
Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.
NAMENDA® / EBIXA® (generic MEMANTINE) is FDA-approved for Alzheimer’s. Learn about new research on how it may help in preventing or slowing dementia.
Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.
People with Alzheimer’s are often prescribed drugs for other conditions — including diabetes or high blood pressure — at the same doses as those without dementia. That practice might need to be reexamined.
Fifty percent of people with Lewy Body Dementia said they were originally misdiagnosed with a type of dementia such as Alzheimer’s. Find out how LBD is exquisitely sensitive to certain medications, and why an early, accurate diagnosis is critical.
See safety and effectiveness rankings for four Alzheimer’s drugs. Ranked on concentration, memory, alertness and mood, learn what the researchers found.
A study at McGill University shows that lithium given in micro doses may be capable of both halting signs of advanced Alzheimer’s pathology and recovering lost cognitive abilities.
Researchers discovered AWE to be a potent predictor of reduced pro-inflammatory cytokines. Can the awe we feel when touched by the beauty of nature, art and spirituality protect us from Alzheimer’s high levels of cytokines?
How can siblings avoid conflict while caring for aging parents? This Resource Guide can help.
Age does not protect you from love, but love to some extent protects you from age.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
